India: Peripheral Arterial Disease, Thromboangiitis Obliterans and Critical Limb Ischemia - Epidemiology and Markets

Questions: Discounts, Updates etc.

Pages: 78

Price (Single): $3400

Price (Departmental):

Price (Company):

Publication Date: 2009-11-12

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Population-based research on the epidemiology of critical limb ischemia (CLI) in India remains almost non-existent.

According to conventional wisdom, the vast majority of CLI in India is caused by Buerger’s Disease, also known as Thromboangiitis Obliterans (TAO). Atherosclerotic lower limb disease, known as peripheral arterial disease (PAD) or peripheral vascular disease (PVD) is considered a “Western Disease” and is generally thought to be rare in the Indian subcontinent.   

As concluded by the India analysis, this is not the case. Afflicting over 20 million citizens, atherosclerotic PAD is many times more prevalent in India than TAO. Compared with PAD, TAO is relatively uncommon in India. Both PAD and atherosclerotic CLI represent major and significantly underestimated problems for the Indian economy and healthcare system.

India contains a comprehensive analysis of the 2008 prevalence of peripheral arterial disease (PAD), thromboangiitis obliterans (TAO) and critical limb ischemia by cause.

The number of people with PAD, TAO and CLI are projected for the 2008-2015 periods. Market analysis includes the number of patients and limbs diagnosed and treated for each disease category.
 
Prevalence is defined as the number of new and old cases of peripheral arterial disease, thromboangiitis obliterans and critical limb ischemia.

Peer-reviewed research on the incidence and prevalence of diabetes, peripheral arterial, disease, TAO and critical limb ischemia in India is reviewed, analyzed and assessed. In addition, the Indian data is compared to published research on incidence and prevalence in the United States and Western Europe.

Peripheral Arterial Disease-related CLI prevalence is calculated based on The Diabetes Method, which was previously validated, in CLI Volume I. The Diabetes Method begins with segmenting the population of each country by age and glucose status, calculating the prevalence of peripheral arterial disease in each glucose category and finally the prevalence of critical ischemia by PAD and glucose status.

Thromboangiitis obliterans prevalence is calculated using a recent study in Bangladesh. CLI caused by TAO is estimated based on an analysis of published research.

In addition to diabetes, the report also analyzes the prevalence of the major risk factors for PAD, TAO & CLI; tobacco use, hypertension, dyslipidemia in the Indian population.
 
An overview of Indian demographics as well as the economic and healthcare system is also provided.

Table of Contents

Download Table of Contents as a PDF

Other users found this report page using the following search terms: Peripheral Arterial Disease PADThromboangiitis Obliterans Critical Limb Ischemia CLI india peripheral disease vascular arterial ischemia incidence prevalence limb critical

If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.